focus -WSS

focus

author：leisure time 2025-09-29 07:30:26 Page View：33

U.S. President Joe Biden stands with his fingers locked next to an US flag — politics coverage from STAT — President Biden's White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs.

WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs, its latest effort to draw attention to the program in an election year.

The news is not controversial: The pharmaceutical companies that make the first ten drugs up for negotiation all submitted counteroffers. It’s an incremental step in the new program, which was created in 2022.

Earlier this year, Medicare sent its initial price offers to the companies. Neither the Biden administration nor the drug manufacturers have volunteered any information about the White House’s initial price offers or the counteroffers. The process is scheduled to end by Aug. 1.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA scientists endorse Pfizer/BioNTech Covid
Next article： Jerome Adams on the need for new antivirals for Covid

focus

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

Type 2 diabetes prevention programs work at large scale: study

LeonNeal/GettyImagesLONDON—Clinicaltrialshaveshownthatlifestyleprograms—whichincludediet,exercise,an

In Memoriam: Notable people who died in 2023

1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

Pharma showers House GOP doctor with campaign cash

Rep.LarryBucshon(R-Ind.)receivedasignificantamountofcampaigndonationsfromthepharmaceuticalindustryin

focus

explore

focus

Pharma showers House GOP doctor with campaign cash